Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Johansen HK and Gøtzsche PC Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. 2014 Cochrane Database Syst Rev pmid:25188769
Gotzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2000 Cochrane Database Syst Rev pmid:10796846
Gøtzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2002 Cochrane Database Syst Rev pmid:12519566
Austin NC and Darlow B Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. 2004 Cochrane Database Syst Rev pmid:14974017
Hac-Wydro K and Dynarowicz-Łatka P Nystatin in Langmuir monolayers at the air/water interface. 2006 Colloids Surf B Biointerfaces pmid:16963237
Kunz D et al. Receptor mediated endocytosis of vicilin in Callosobruchus maculatus (Coleoptera: Chrysomelidae) larval midgut epithelial cells. 2017 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:28630013
Gupte TE et al. Experimental studies (in vitro) on polyene macrolide antibiotics with special reference to hamycin against Malassezia ovale. 1999 Comp. Immunol. Microbiol. Infect. Dis. pmid:10051180
Cooper SM and Shaw S Contact allergy to nystatin: an unusual allergen. 1999 Contact Derm. pmid:10445710
Orton DI and Shaw S Allergic contact dermatitis from pharmaceutical grade BHA in Timodine, with no patch test reaction to analytical grade BHA. 2001 Contact Derm. pmid:11218002
Wilkinson SM and Beck MH Allergic contact dermatitis from dibutyl phthalate, propyl gallate and hydrocortisone in Timodine. 1992 Contact Derm. pmid:1451476
Van Hecke E Ethylenediamine sensitivity from exposure to epoxy resin hardeners and Mycolog cream. 1975 Contact Derm. pmid:66117
Barranco R et al. Type IV hypersensitivity to oral nystatin. 2001 Contact Derm. pmid:11422284
Cooper SM et al. Systemic reaction to nystatin. 1999 Contact Derm. pmid:10617220
Lang E and Goos M Combined allergy to tolnaftate and nystatin. 1985 Contact Derm. pmid:3995953
Martínez FV et al. Delayed hypersensitivity to oral nystatin. 2007 Contact Derm. pmid:17680880
Quirce S et al. Generalized dermatitis due to oral nystatin. 1991 Contact Derm. pmid:1838322
Hills RJ and Ive FA Contact sensitivity to nystatin in Timodine. 1993 Contact Derm. pmid:8428456
Bistner SI and Riis RC Clinical aspects of mycotic keratitis in the horse. 1979 Cornell Vet pmid:316757
White RW Control of the yeast Torulopsis glabrata in the stomachs of glucose fed lambs by oral dosing with nystatin and amphotericin "B". 1977 Cornell Vet pmid:558083
WINTER AJ et al. AN EVALUATION OF CULTURAL TECHNICS FOR THE DETECTION OF VIBRIO FETUS IN BOVINE SEMEN. 1965 Cornell Vet pmid:14343835
Ceccarelli G et al. Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. 2013 Crit Care pmid:23414732
Hingston CD et al. Impact of nystatin on Candida and the oral microbiome. 2012 Crit Care pmid:22827886
Giglio M et al. Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. 2012 Crit Care pmid:22490643
Lister G Metabolic responses to hypoxia. 1993 Crit. Care Med. pmid:8395993
Vanden Bossche H et al. Anti-Candida drugs--the biochemical basis for their activity. 1987 Crit. Rev. Microbiol. pmid:3319421
Hotta J et al. Intraoral Device for Optimal Antifungal Delivery in a Rat Model. 2017 Curr Drug Deliv pmid:27739378
Perchyonok VT et al. Chitosan and gelatin based prototype delivery systems for the treatment of oral mucositis: from material to performance in vitro. 2013 Curr Drug Deliv pmid:23017090
Pigott PV An evaluation of a modified nystatin vaginal tablet in a multi-centre study. 1972 Curr Med Res Opin pmid:4589710
Milne LJ and Brown AD Comparison of nystatin ('Nystan') and hydrargaphen ('Penotrane') in the treatment of vaginal candidosis in pregnancy. 1973 Curr Med Res Opin pmid:4591821
Beveridge GW et al. A comparison of nystatin cream with nystatin/triamcinolone acetonide combination cream in the treatment of candidal inflammation of the flexures. 1977 Curr Med Res Opin pmid:326494
Masterton G et al. Six-day clotrimazole therapy in vaginal candidosis. 1975 Curr Med Res Opin pmid:1095310
Hilton AL et al. Treatment of vaginal candidiasis with miconazole. 1977-1978 Curr Med Res Opin pmid:630905
Isaacs D Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? 2008 Curr. Opin. Infect. Dis. pmid:18448968
Moribe K and Maruyama K Pharmaceutical design of the liposomal antimicrobial agents for infectious disease. 2002 Curr. Pharm. Des. pmid:12069381
Frey Tirri B Antimicrobial topical agents used in the vagina. 2011 Curr. Probl. Dermatol. pmid:21325838
Vega F et al. Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis. 2016 Cutis pmid:26919353
Tallury P et al. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer. 2007 Dent Mater pmid:17049593
Lin DM et al. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release. 2003 Dent Mater pmid:12901982
Ellepola AN and Samaranayake LP Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. 2000 Dent Update pmid:11218451
Yap FB et al. Penicillium marneffei infection in an African man. 2010 Dermatol. Online J. pmid:20673530
Pavlović MD and Bulajić N Great toenail onychomycosis caused by Syncephalastrum racemosum. 2006 Dermatol. Online J. pmid:16638375
Torres-Alvarez B et al. Cutaneous congenital candidiasis in a full-term newborn from an asymptomatic mother. 2013 Dermatol. Online J. pmid:24010513
Rahn R et al. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. 1997 Dermatology (Basel) pmid:9403257
Oppenheimer SB et al. Alteration of sea urchin embryo cell surface properties by mycostatin, a sterol binding antibiotic. 1973 Dev. Biol. pmid:4789600
Soll DR et al. Characterization of a timing mutant of Dictyostelium discoideum which exhibits "high frequency switching". 1987 Dev. Biol. pmid:3102295
Sardi JC et al. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp. 2016 Diagn. Microbiol. Infect. Dis. pmid:27638348
Colosimo ME and Katz ER Altered prestarvation response in a nystatin resistant Dictyostelium discoideum mutant. 2001 Differentiation pmid:11270118
Madden JL et al. Preoperative preparation and postoperative care of the colon. 1968 May-Jun Dis. Colon Rectum pmid:4299091
COHN I INTESTINAL ANTISEPSIS. 1965 Jan-Feb Dis. Colon Rectum pmid:14254999
Farran L et al. Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. 2008 Dis. Esophagus pmid:18269652
Trujillo MA et al. Clustering of the B cell receptor is not required for the apoptotic response. 2003 DNA Cell Biol. pmid:14565868
Bouallegui Y et al. Effect of exposure time, particle size and uptake pathways in immune cell lysosomal cytotoxicity of mussels exposed to silver nanoparticles. 2018 Drug Chem Toxicol pmid:28583008
Lyu X et al. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. 2016 Drug Des Devel Ther pmid:27042008
El-Ridy MS et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. 2011 Drug Dev Ind Pharm pmid:21707323
de Aguiar MM et al. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. 2010 Drug Dev Ind Pharm pmid:19954405
Worthen DR et al. Methods for the recovery and purification of polyene antifungals. 2001 Drug Dev Ind Pharm pmid:11411895
Vaginal candidosis (moniliasis). 1976 Drug Ther Bull pmid:964136
Dennerstein GJ Vaginitis: diagnosis and treatment. 1972 Drugs pmid:4568067
Nystatin--liposomal. AR 121, Nyotran. 1999 Drugs R D pmid:10566021
Roser H [Treatment of unspecific urethritis]. 1975 Dtsch. Med. Wochenschr. pmid:1112234
Baier R and Puppel H [Antimycotic sensitivity of yeast from clinical specimens (author's transl)]. 1978 Dtsch. Med. Wochenschr. pmid:307486
Meinhof W [Treatment of Candida mycoses of skin and mucous membranes]. 1970 Dtsch. Med. Wochenschr. pmid:5310512
Schmitz N et al. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center]. 1985 Dtsch. Med. Wochenschr. pmid:3896727
Müller M et al. [Pulmonary aspergillosis in an immunocompetent female patient]. 1994 Dtsch. Med. Wochenschr. pmid:8194452
Zazgornik J et al. [Fungal infections after renal transplantation (author's transl)]. 1975 Dtsch. Med. Wochenschr. pmid:1100337
HAMER P and PETERSEN A [FARMER'S LUNG]. 1965 Dtsch. Med. Wochenschr. pmid:14242202
Wegmann T [Treatment of the lung mycoses]. 1969 Dtsch. Med. Wochenschr. pmid:5352271
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Raith K et al. Two examples of rapid and simple drug analysis in pharmaceutical formulations using capillary electrophoresis: naphazoline, dexamethasone and benzalkonium in nose drops and nystatin in an oily suspension. 1998 Electrophoresis pmid:9870387
Blot V and McGraw TE GLUT4 is internalized by a cholesterol-dependent nystatin-sensitive mechanism inhibited by insulin. 2006 EMBO J. pmid:17139247
Tempark T et al. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. 2010 Endocrine pmid:20972726
Gadd GM New horizons in geomycology. 2017 Environ Microbiol Rep pmid:27701824
Clark RS et al. Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection. 2016 Environ. Res. pmid:26765097
Masood A et al. A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa. 2008 Eur Arch Otorhinolaryngol pmid:17922130
Anderson O and Takwoingi YM Tri-adcortyl ointment ear dressing in myringoplasty: an analysis of outcome. 2007 Eur Arch Otorhinolaryngol pmid:17361408
Ulrych A et al. Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides. 2010 Eur J Mass Spectrom (Chichester, Eng) pmid:20065516
Bassi P and Kaur G Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization. 2015 Eur J Pharm Biopharm pmid:26235393
Pál S et al. Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system. 2013 Eur J Pharm Sci pmid:23528741
des Rieux A et al. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. 2007 Eur J Pharm Sci pmid:17291730
Di Capua R et al. Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology. 2012 Eur. Biophys. J. pmid:22237602
Schwencke J and De Robichon-Szulmajster H The transport of S-adenosyl-L-methionine in isolated yeast vacuoles and spheroplasts. 1976 Eur. J. Biochem. pmid:6283
Komor E and Tanner W The determination of the membrane ptoential of Chlorella vulgaris. Evidence for electrogenic sugar transport. 1976 Eur. J. Biochem. pmid:12943
Volpon L and Lancelin JM Solution NMR structure of five representative glycosylated polyene macrolide antibiotics with a sterol-dependent antifungal activity. 2002 Eur. J. Biochem. pmid:12230565
Nolan DP and Voorheis HP Hydrogen ion gradients across the mitochondrial, endosomal and plasma membranes in bloodstream forms of trypanosoma brucei solving the three-compartment problem. 2000 Eur. J. Biochem. pmid:10903492
Young GA et al. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group. 1999 Eur. J. Cancer pmid:10615231
Wasan KM and Lopez-Berestein G Diversity of lipid-based polyene formulations and their behavior in biological systems. 1997 Eur. J. Clin. Microbiol. Infect. Dis. pmid:9063678
Ruza F et al. Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. 1998 Eur. J. Epidemiol. pmid:9849834
Demirel G et al. Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. 2013 Eur. J. Pediatr. pmid:23703468
Harvey AL and Marshall IG The actions of three diaminopyridines on the chick biventer cervicis muscle. 1977 Eur. J. Pharmacol. pmid:196864
Taylor CT et al. Berberine inhibits ion transport in human colonic epithelia. 1999 Eur. J. Pharmacol. pmid:10096776
Jeong HJ et al. Role of protein kinase C in opioid modulation of glycine-gated Cl(-) current in rat periaqueductal gray neuron. 2001 Eur. J. Pharmacol. pmid:11728420
Caruso A et al. Parathyroid hormone fragment 1-34 inhibits drug-induced inflammation in various experimental models. 1991 Eur. J. Pharmacol. pmid:1717293
Arrigoni-Martelli E and Restelli A Release of lysosomal enzymes in experimental inflammations: effects of anti-inflammatory drugs. 1972 Eur. J. Pharmacol. pmid:5071790
Lee JJ et al. 5-HT1A receptor-mediated activation of a G-protein-coupled inwardly rectifying K+ current in rat medial preoptic area neurons. 2008 Eur. J. Pharmacol. pmid:18367171
Lobie PE et al. Caveolar internalization of growth hormone. 1999 Exp. Cell Res. pmid:9882514
Chen Y and Norkin LC Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. 1999 Exp. Cell Res. pmid:9882517
Norkin LC et al. Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection. 2001 Exp. Cell Res. pmid:11399051
Stuart ES et al. Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells. 2003 Exp. Cell Res. pmid:12799183
Simpson JC et al. Expression of mutant dynamin protects cells against diphtheria toxin but not against ricin. 1998 Exp. Cell Res. pmid:9521846
Inal J et al. The complement inhibitor, CRIT, undergoes clathrin-dependent endocytosis. 2005 Exp. Cell Res. pmid:16112669